| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 149, Issue 2 535-540, Copyright © 1992 by American Association of Immunologists
ARTICLES |
G Rodriguez-Tarduchy, MK Collins, I Garcia and A Lopez-Rivas
Instituto de Investigaciones Biomedicas CSIC, Facultad de Medicina UAM, Spain.
The death of hemopoietic cells on withdrawal of CSF occurs by a mechanism known as apoptosis characterized by the early degradation of chromatin into oligonucleosome-length fragments. Insulin-like growth factor I plays a pivotal role in the regulation of somatic cell growth as a mediator of growth hormone action. Animals with low levels of circulating IGF-I are more vulnerable to infections and have diminished immune responses. To analyze the possibility of a regulatory role of IGF-I on hemopoiesis and determine its mechanism of action, we have studied the effect of this growth factor on the survival and proliferation of two IL-3-dependent hemopoietic cell lines and in IL-3- responsive primary cultures of bone marrow-derived mast cells. In IL-3- depleted cultures, IGF-I prevented DNA fragmentation and apoptotic cell death. Insulin at high concentration had a weak protective action and IGF-II was inactive in suppressing apoptosis in these IL-3-dependent hemopoietic cells. Cell proliferation was also stimulated by IGF-I in the absence of other hemopoietic growth factors although it was a weak mitogen when compared with IL-3. These results indicate that circulating or locally produced IGF-I may promote survival of both the steady state hemopoietic precursor population and cytokine-producing cells and could therefore regulate hemopoiesis acting in a concerted manner with other CSF.
This article has been cited by other articles:
|
|
 |
|
  H. Chung, S. Seo, M. Moon, and S. Park IGF-I inhibition of apoptosis is associated with decreased expression of prostate apoptosis response-4 J. Endocrinol., July 1, 2007; 194(1): 77 - 85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Lessmann, M. Leitges, and M. Huber A redundant role for PKC-{varepsilon} in mast cell signaling and effector function Int. Immunol., May 1, 2006; 18(5): 767 - 773. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, J. Hailey, D. Williams, Y. Wang, P. Lipari, M. Malkowski, X. Wang, L. Xie, G. Li, D. Saha, et al. Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody Mol. Cancer Ther., August 1, 2005; 4(8): 1214 - 1221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Toyoshima, M. Karas, S. Yakar, J. Dupont, Lee Helman, and D. LeRoith TDAG51 Mediates the Effects of Insulin-like Growth Factor I (IGF-I) on Cell Survival J. Biol. Chem., June 11, 2004; 279(24): 25898 - 25904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Schneider, N. Ad, U. Izhar, I. Khaliulin, J. B. Borman, and H. Schwalb Protection of myocardium by cyclosporin A and insulin: in vitro simulated ischemia study in human myocardium Ann. Thorac. Surg., October 1, 2003; 76(4): 1240 - 1245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J A Mohammed, A Y. Mok, A Parbtani, and D G Matsell Increased expression of insulin-like growth factors in progressive glomerulonephritis of the MRL lpr mouse Lupus, August 1, 2003; 12(8): 584 - 590. [Abstract] [PDF]
|
|
|
|
 |
|
 K. Hensen, I. C. C. Van Valckenborgh, K. Kas, W. J. M. Van de Ven, and M. L. Voz The Tumorigenic Diversity of the Three PLAG Family Members Is Associated with Different DNA Binding Capacities Cancer Res., March 1, 2002; 62(5): 1510 - 1517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Fonteh, C. R. Marion, B. J. Barham, M. B. Edens, G.-i. Atsumi, J. M. Samet, K. P. High, and F. H. Chilton Enhancement of Mast Cell Survival: A Novel Function of Some Secretory Phospholipase A2 Isotypes J. Immunol., October 15, 2001; 167(8): 4161 - 4171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Prisco, F. Peruzzi, B. Belletti, and R. Baserga Regulation of Id Gene Expression by Type I Insulin-Like Growth Factor: Roles of STAT3 and the Tyrosine 950 Residue of the Receptor Mol. Cell. Biol., August 15, 2001; 21(16): 5447 - 5458. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Spanos, D. L. Becker, R. M.L. Winston, and K. Hardy Anti-Apoptotic Action of Insulin-Like Growth Factor-I During Human Preimplantation Embryo Development Biol Reprod, November 1, 2000; 63(5): 1413 - 1420. [Abstract] [Full Text]
|
|
|
|
|
|
W. Tu, P.-T. Cheung, and Y.-L. Lau Insulin-Like Growth Factor 1 Promotes Cord Blood T Cell Maturation and Inhibits Its Spontaneous and Phytohemagglutinin-Induced Apoptosis Through Different Mechanisms J. Immunol., August 1, 2000; 165(3): 1331 - 1336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Dorshkind and N. D. Horseman The Roles of Prolactin, Growth Hormone, Insulin-Like Growth Factor-I, and Thyroid Hormones in Lymphocyte Development and Function: Insights from Genetic Models of Hormone and Hormone Receptor Deficiency Endocr. Rev., June 1, 2000; 21(3): 292 - 312. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Vogt, A. S. Wang, C. S. Johnson, J. P. Fabisiak, P. Wipf, and J. S. Lazo In Vivo Antitumor Activity and Induction of Insulin-Like Growth Factor-1-Resistant Apoptosis by SC-alpha alpha delta 9 J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 530 - 537. [Abstract] [Full Text]
|
|
|
|
|
|
F. Peruzzi, M. Prisco, M. Dews, P. Salomoni, E. Grassilli, G. Romano, B. Calabretta, and R. Baserga Multiple Signaling Pathways of the Insulin-Like Growth Factor 1 Receptor in Protection from Apoptosis Mol. Cell. Biol., October 1, 1999; 19(10): 7203 - 7215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Valentinis, G. Romano, F. Peruzzi, A. Morrione, M. Prisco, S. Soddu, B. Cristofanelli, A. Sacchi, and R. Baserga Growth and Differentiation Signals by the Insulin-like Growth Factor 1 Receptor in Hemopoietic Cells Are Mediated through Different Pathways J. Biol. Chem., April 30, 1999; 274(18): 12423 - 12430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Leri, Y. Liu, X. Wang, J. Kajstura, A. Malhotra, L. G. Meggs, and P. Anversa Overexpression of Insulin-Like Growth Factor-1 Attenuates the Myocyte Renin-Angiotensin System in Transgenic Mice Circ. Res., April 16, 1999; 84(7): 752 - 762. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Farrelly, Y.-J. Lee, J. Oliver, C. Dive, and C. H. Streuli Extracellular Matrix Regulates Apoptosis in Mammary Epithelium through a Control on Insulin Signaling J. Cell Biol., March 22, 1999; 144(6): 1337 - 1348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Leri, Y. Liu, P. P. Claudio, J. Kajstura, X. Wang, S. Wang, P. Kang, A. Malhotra, and P. Anversa Insulin-Like Growth Factor-1 Induces Mdm2 and Down-Regulates p53, Attenuating the Myocyte Renin-Angiotensin System and Stretch-Mediated Apoptosis Am. J. Pathol., February 1, 1999; 154(2): 567 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Matsuda, H. Saito, T. Inoue, K. Fukatsu, I. Han, S. Furukawa, S. Ikeda, and T. Muto Growth Hormone Inhibits Apoptosis and Up-Regulates Reactive Oxygen Intermediates Production by Human Polymorphonuclear Neutrophils JPEN J Parenter Enteral Nutr, November 1, 1998; 22(6): 368 - 374. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Niebauer, C.-D. Pflaum, A. L. Clark, C. J. Strasburger, J. Hooper, P. A. Poole-Wilson, A. J. S. Coats, and S. D. Anker Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation J. Am. Coll. Cardiol., August 1, 1998; 32(2): 393 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Hinton, C. A. Peterson, E. M. Dahly, and D. M. Ney IGF-I alters lymphocyte survival and regeneration in thymus and spleen after dexamethasone treatment Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1998; 274(4): R912 - R920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Boehm, O. V. Chaika, and R. E. Lewis Anti-apoptotic Signaling by a Colony-stimulating Factor-1 Receptor/Insulin Receptor Chimera with a Juxtamembrane Deletion J. Biol. Chem., March 20, 1998; 273(12): 7169 - 7176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Liu, W. Ning, R. Dantzer, G. G. Freund, and K. W. Kelley Activation of Protein Kinase C-{zeta} and Phosphatidylinositol 3'-Kinase and Promotion of Macrophage Differentiation by Insulin-Like Growth Factor-I J. Immunol., February 1, 1998; 160(3): 1393 - 1401. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Frago, Y Leon, E. de la Rosa, A Gomez-Munoz, and I Varela-Nieto Nerve growth factor and ceramides modulate cell death in the early developing inner ear J. Cell Sci., January 3, 1998; 111(5): 549 - 556. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Navarro, B. Barenton, V. Garandel, J. Schnekenburger, and H. Bernardi Insulin-Like Growth Factor I (IGF-I) Receptor Overexpression Abolishes the IGF Requirement for Differentiation and Induces a Ligand-Dependent Transformed Phenotype in C2 Inducible Myoblasts Endocrinology, December 1, 1997; 138(12): 5210 - 5219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Schwab, M. Spranger, S. Krempien, W. Hacke, and M. Bettendorf Plasma Insulin-like Growth Factor I and IGF Binding Protein 3 Levels in Patients With Acute Cerebral Ischemic Injury Stroke, September 1, 1997; 28(9): 1744 - 1748. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Dore, S. Kar, and R. Quirion Insulin-like growth factor I protects and rescues hippocampal neurons against beta -amyloid- and human amylin-induced toxicity PNAS, April 29, 1997; 94(9): 4772 - 4777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Silva, A. Wyllie, and M. K.L. Collins p53 Is Not Required for Regulation of Apoptosis or Radioprotection by Interleukin-3 Blood, April 15, 1997; 89(8): 2717 - 2722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Clark The Somatogenic Hormones and Insulin-Like Growth Factor-1: Stimulators of Lymphopoiesis and Immune Function Endocr. Rev., April 1, 1997; 18(2): 157 - 179. [Abstract] [Full Text]
|
|
|
|
|
|
M. Parrizas, A. Gazit, A. Levitzki, E. Wertheimer, and D. LeRoith Specific Inhibition of Insulin-Like Growth Factor-1 and Insulin Receptor Tyrosine Kinase Activity and Biological Function by Tyrphostins Endocrinology, April 1, 1997; 138(4): 1427 - 1433. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Manes, L. Kremer, J. P. Albar, C. Mark, R. Llopis, and C. Martinez-A Functional Epitope Mapping of Insulin-Like Growth Factor I (IGF-I) by Anti-IGF-I Monoclonal Antibodies Endocrinology, March 1, 1997; 138(3): 905 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Parrizas, A. R. Saltiel, and D. LeRoith Insulin-like Growth Factor 1Inhibits Apoptosis Using the Phosphatidylinositol 3'-Kinase and Mitogen-activated Protein Kinase Pathways J. Biol. Chem., January 3, 1997; 272(1): 154 - 161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. H. Stewart and P. Rotwein Insulin-like Growth Factor-II Is an Autocrine Survival Factor for Differentiating Myoblasts J. Biol. Chem., May 10, 1996; 271(19): 11330 - 11338. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Palumbo and J. Yeh Apoptosis as a Basic Mechanism in the Ovarian Cycle: Folicular Atresia and Luteal Regression Reproductive Sciences, May 1, 1995; 2(3): 565 - 573. [Abstract] [PDF]
|
|
|
|
|
|
C. S. Zong, J. Chan, D. E. Levy, C. Horvath, H. B. Sadowski, and L.-H. Wang Mechanism of STAT3 Activation by Insulin-like Growth Factor I Receptor J. Biol. Chem., May 12, 2000; 275(20): 15099 - 15105. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Valentinis, M. Navarro, T. Zanocco-Marani, P. Edmonds, J. McCormick, A. Morrione, A. Sacchi, G. Romano, K. Reiss, and R. Baserga Insulin Receptor Substrate-1, p70S6K, and Cell Size in Transformation and Differentiation of Hemopoietic Cells J. Biol. Chem., August 11, 2000; 275(33): 25451 - 25459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Krause, A. Lyons, C. Fennelly, and R. O'Connor Transient Activation of Jun N-terminal Kinases and Protection from Apoptosis by the Insulin-like Growth Factor I Receptor Can Be Suppressed by Dicumarol J. Biol. Chem., May 25, 2001; 276(22): 19244 - 19252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Heron-Milhavet, M. Karas, C. M. Goldsmith, B. J. Baum, and D. LeRoith Insulin-like Growth Factor-I (IGF-I) Receptor Activation Rescues UV-damaged Cells through a p38 Signaling Pathway. POTENTIAL ROLE OF THE IGF-I RECEPTOR IN DNA REPAIR J. Biol. Chem., May 18, 2001; 276(21): 18185 - 18192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Peruzzi, M. Prisco, A. Morrione, B. Valentinis, and R. Baserga Anti-apoptotic Signaling of the Insulin-like Growth Factor-I Receptor through Mitochondrial Translocation of c-Raf and Nedd4 J. Biol. Chem., July 6, 2001; 276(28): 25990 - 25996. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Huang, D. Hutter, Y. Liu, X. Wang, M. S. Sheikh, A. M-L. Chan, and N. J. Holbrook Transforming Growth Factor-beta 1 Suppresses Serum Deprivation-induced Death of A549 Cells through Differential Effects on c-Jun and JNK Activities J. Biol. Chem., June 9, 2000; 275(24): 18234 - 18242. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
